Essential role of TGF-β in the natural resistance to experimental allergic encephalomyelitis in rats

European Journal of Immunology

Volumn 31, Issue 4, 2001, Pages 1132-1140

  Cautain, Bastien ^a   Damoiseaux, Jan ^b   Bernard, Isabelle ^a   van Straaten, Henny ^b   van Breda Vriesman, Peter ^b   Boneu, Bernard ^c   Druet, Philippe ^a   Saoudi, Abdelhadi ^a  

^a INSERM   (France)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c CHU PURPAN   (France)

Author keywords

Autoimmune; Cytokine; Experimental allergic encephalomyelitis; Rodent; Suppression

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; NEUTRALIZING ANTIBODY; REGULATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CONGENIC STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE RESISTANCE; FEMALE; GENETIC CODE; IMMUNITY; IMMUNIZATION; LYMPH NODE CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; RAT STRAIN; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD45; BLOOD PLATELETS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DISEASE SUSCEPTIBILITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LYMPH NODES; MYELIN BASIC PROTEINS; NEUTRALIZATION TESTS; RATS; RATS, INBRED BN; RATS, INBRED LEW; RNA, MESSENGER; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0035060553     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200104)31:4<1132::AID-IMMU1132>3.0.CO;2-N     Document Type: Article

References (43)

1. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
2. Analysis of autoimmune demyelination: Its impact upon multiple sclerosis
3. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of interleukin 4 and prostaglandin
4. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: Dynamics of cellular mRNA expression in the central nervous system and lymhoid cells
5. Encephalithogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype
6. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistanc mice
7. Myelin basic protein-specific T helper (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
8. Genetic control of susceptibility to experimental allergic encephalomyelitis and the Ag-B locus of rats
9. Association between susceptibility to experimental allergic encephalomyelitis and the major histocompatibility system in congenic rat strains
10. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis
11. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles
12. Genetic control of the development of experimental allergic encephalomyelitis in rats: Separation of MHC and non-MHC effects
13. Rat interleukin-4 assays
14. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: Evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of T cells
15. - thymocytes
16. The physiological role of regulatory T cells in the prevention of autoimmunity: The function of the thymus in the generation of the regulatory T cell subset
17. + T-cell subsets in autoimmunity
18. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
19. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor
20. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1
21. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1
22. Genetic influence on disease course and cytokine response in relapsing experimental allergic encephalomyelitis
23. Experimental allergic encephalomyelitis: Neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease
24. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis
25. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering
26. Regulation of immune responses by TGF-β
27. TGFβ: From latent to active
28. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
29. + T lymphocytes
30. + T cells
31. + T cell subset that inhibits this autoimmune potential
32. Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis
33. Experimental allergic encephalomyelitis: Successful treatment in vivo with a monoclonal antibody that recognizes T helper cells
34. + T cells in vitro
35. The autocrine production of transforming growth factor-β1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA
36. Purification of human C3b inactivator by monoclonal-antibody affinity chromatography
37. Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted
38. Two subsets of rat T lymphocytes defined with monoclonal antibodies
39. Analysis of cell surface by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes
40. MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen
41. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes
42. Isolation and characterisation of monoclonal antibodies directed to rat interferon-gamma
43. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats